Histologically proved endometrial carcinoma preoperatively supposed stage I-II
Showing 1 - 25 of >10,000
Cancer Survivor, Endometrial Carcinoma, Stage I Uterine Corpus Cancer AJCC v7 Trial in Palo Alto, San Jose (Communication
Active, not recruiting
- Cancer Survivor
- +6 more
- Communication Intervention
- +5 more
-
Palo Alto, California
- +1 more
Oct 24, 2022
Obesity, Endometrial Carcinoma Trial in Columbus (Gentle yoga therapy, counseling intervention, educational intervention)
Active, not recruiting
- Obesity
- Endometrial Carcinoma
- Gentle yoga therapy
- +4 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Jun 3, 2022
Among Reproductive Age Gynecological and Breast Cancer
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +29 more
- Healthcare Activity
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Nov 2, 2022
Endometrial Cancer, Endometrial Tumors, Endometrial Adenocarcinoma Trial in Istra (Laparoscopic hysterectomy with sentinel lymph
Recruiting
- Endometrial Cancer
- +8 more
- Laparoscopic hysterectomy with sentinel lymph node biopsy
-
Istra, Moscow Region, Russian FederationDepartment of Gynecologic Oncology, Moscow City Oncology Hospita
Oct 8, 2021
Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)
Recruiting
- Endometrial Adenocarcinoma
- Comparison of adjuvant therapies
-
Helsinki, FinlandHelsinki University Hospital
Dec 8, 2022
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Stage I Endometrial Carcinoma, Stage II Endometrial Carcinoma, Stage III Endometrial Carcinoma Trial in Cleveland (lymph node
Terminated
- Stage I Endometrial Carcinoma
- +3 more
- lymph node mapping
- +5 more
-
Cleveland, OhioCleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 26, 2020
Endometrial Carcinoma, Tumor Molecular Features Screening Model Trial (open surgery, laparoscopic surgery)
Not yet recruiting
- Endometrial Carcinoma
- Tumor Molecular Features Screening Model
- open surgery
- laparoscopic surgery
- (no location specified)
Jun 7, 2023
Endometrial Cancer, Endometrial Tumors, Obesity, Morbid Trial (Robot-assisted surgery, Laparoscopic surgery)
Not yet recruiting
- Endometrial Cancer
- +4 more
- Robot-assisted surgery
- Laparoscopic surgery
- (no location specified)
Jul 25, 2023
Recurrent Endometrial Carcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Refractory Endometrial Carcinoma Trial in
Recruiting
- Recurrent Endometrial Carcinoma
- +12 more
- Everolimus
- +2 more
-
Houston, Texas
- +1 more
Sep 22, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Endometrial Endometrioid Adenocarcinoma, Stage I Uterine Corpus Cancer AJCC v8, Stage IA Uterine Corpus Cancer AJCC v8 Trial in
Active, not recruiting
- Endometrial Endometrioid Adenocarcinoma
- +4 more
- Brachytherapy
- +4 more
-
Birmingham, Alabama
- +277 more
Sep 16, 2022
Moesin in Endometrial Hyperplasia and Endometrial Carcinoma
Not yet recruiting
- Endometrial Cancer and Endometrial Hyperplasia
- microscopic pathological evaluation
-
Sohag, EgyptSohag University Hospital
Nov 8, 2022
Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New
Withdrawn
- Endometrial Carcinoma
- +55 more
- Internet-Based Intervention
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 16, 2021
Endometrial Cancer Treatment Development
Completed
- Endometrial Cancer Stage
-
Yunusemre, Mani̇sa, TurkeyManisa Celal Bayar University
Jun 13, 2023
Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid
Recruiting
- Atypical Endometrial Hyperplasia
- +2 more
- Everolimus
- +2 more
-
Greeley, Colorado
- +17 more
Jun 13, 2022
Staging Endometrial caNcer Based on molEcular ClAssification
Recruiting
- Endometrial Cancer
- +2 more
-
Pamplona, Navarra, SpainClinica Universidad de Navarra
Jan 30, 2023
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma Trial in Canada, United States
Active, not recruiting
- Advanced Endometrial Carcinoma
- +4 more
- Cabozantinib S-malate
- Nivolumab
-
Phoenix, Arizona
- +33 more
Nov 1, 2022
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Breast Tumors Trial in Saint Louis (accelerated partial breast irradiation)
Active, not recruiting
- Breast Neoplasms
- accelerated partial breast irradiation
-
Saint Louis, MissouriWashington University School of Medicine
Nov 14, 2022
Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)
Active, not recruiting
- Endometrial Cancer
- Uterine Carcinosarcoma
- Rucaparib
- +2 more
-
New York, New York
- +2 more
Apr 4, 2022
Early Development of Endometrial Carcinoma
Recruiting
- Cancer of Endometrium
-
Ferrara, ItalySection of Obstetrics and Gynecology, Department of Morphology,
Apr 4, 2022
Chemo-refractory Colorectal Carcinoma Trial in Hamburg, Ulm (Maximum tolerated dose, MTD: D,L-methadone HCl (Methasan® 10
Recruiting
- Chemo-refractory Colorectal Carcinoma
- Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
-
Hamburg, Germany
- +1 more
Apr 21, 2022
Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma
Recruiting
- Esophageal Squamous Cell Carcinoma
-
Shijiazhuang, Hebei, ChinaDepartment of Thoracic Surgery, Fourth Hospital of Hebei Medical
Oct 25, 2023